ask="N/A"
ask_size="N/A"
average_daily_volume="210517"
bid="4.09"
bid_size="1700"
book_value="0.56"
change="+0.16"
change_from_200_day_moving_average="1.54"
change_from_50_day_moving_average="0.62"
change_from_52_week_high="-0.45"
change_From_52_week_low="2.19"
change_in_percent="+3.91%"
close="4.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.98"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.30"
high_52_weeks="4.70"
last_trade_date="3/15/2017"
last_trade_price="4.25"
last_trade_size="1066"
last_trade_time="4:00pm"
low="4.09"
low_52_weeks="2.06"
market_capitalization="79.42M"
moving_average_200_day="2.71"
moving_average_50_day="3.63"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="5.00"
open="4.12"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+57.00%"
percent_change_from_50_day_moving_average="+17.05%"
percent_change_from_52_week_high="-9.57%"
percent_change_from_52_week_low="+106.30%"
previous_close="4.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.26"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="3.19"
stock_exchange="NCM"
symbol="BCLI"
volume="133520"
weeks_range_52="2.06 - 4.70"
